|
18 Sep 2025 |
SBI Life Insurance
|
Consensus Share Price Target
|
1821.80 |
2077.79 |
- |
14.05 |
buy
|
|
|
|
|
27 Jan 2024
|
SBI Life Insurance
|
BOB Capital Markets Ltd.
|
1821.80
|
1970.00
|
1380.90
(31.93%)
|
|
Buy
|
|
|
9MFY24 APE growth strong at 17% YoY with ULIPs forming 61% of total; continues to lead the market with 26.5% share in individual APE
|
|
23 Jan 2024
|
SBI Life Insurance
|
IDBI Capital
|
1821.80
|
1575.00
|
1375.50
(32.45%)
|
Target met |
Buy
|
|
|
|
|
03 Jan 2024
|
SBI Life Insurance
|
IDBI Capital
|
1821.80
|
1575.00
|
1422.70
(28.05%)
|
Target met |
Buy
|
|
|
|
|
30 Oct 2023
|
SBI Life Insurance
|
Axis Direct
|
1821.80
|
1535.00
|
1326.20
(37.37%)
|
Target met |
Buy
|
|
|
We maintain our BUY recommendation on the stock.
|
|
30 Oct 2023
|
SBI Life Insurance
|
SMC online
|
1821.80
|
|
1326.20
(37.37%)
|
|
Results Update
|
|
|
|
|
29 Oct 2023
|
SBI Life Insurance
|
ICICI Securities Limited
|
1821.80
|
1650.00
|
1302.90
(39.83%)
|
Target met |
Buy
|
|
|
Overall, volume growth and margin performance remains better than peers for SBI Life (SBLI) on the back of minimal disruption in distribution from open architecture and broad-based customer segment with low concentration of high ticket size mix. This has enabled continuous near 20% RoEV for the last four years, which could lead to better valuation multiples.
|
|
28 Oct 2023
|
SBI Life Insurance
|
BOB Capital Markets Ltd.
|
1821.80
|
1650.00
|
1302.90
(39.83%)
|
Target met |
Buy
|
|
|
H1 APE growth strong at 21% YoY led by a rebound in ULIP and protection business during Q2
|
|
06 Sep 2023
|
SBI Life Insurance
|
IDBI Capital
|
1821.80
|
1575.00
|
1319.80
(38.04%)
|
Target met |
Buy
|
|
|
|
|
26 Jul 2023
|
SBI Life Insurance
|
BOB Capital Markets Ltd.
|
1821.80
|
1500.00
|
1292.65
(40.94%)
|
Target met |
Buy
|
|
|
Q1 APE growth softened to 4% YoY as non-par business slowed; management optimistic of a rebound
|
|
26 Jul 2023
|
SBI Life Insurance
|
SMC online
|
1821.80
|
|
1292.65
(40.94%)
|
|
Results Update
|
|
|
|